Candidiasis of skin and nail
ICD-10 B40.2 is a billable code used to indicate a diagnosis of candidiasis of skin and nail.
Candidiasis of the skin and nails is a fungal infection caused by Candida species, most commonly Candida albicans. This condition typically manifests as red, itchy, and inflamed skin, often accompanied by scaling and peeling. In the case of nail involvement, it can lead to discoloration, thickening, and separation of the nail from the nail bed. Candidiasis is more prevalent in individuals with compromised immune systems, such as those with diabetes, HIV/AIDS, or undergoing immunosuppressive therapy. The infection can occur in warm, moist areas of the body, including the groin, armpits, and between the toes. Diagnosis is primarily clinical, supported by laboratory tests such as KOH preparations or cultures. Treatment typically involves topical antifungal agents like clotrimazole or miconazole for skin infections, while systemic antifungals like fluconazole may be necessary for more severe cases or nail involvement. Proper management is crucial to prevent recurrence, especially in immunocompromised patients.
Detailed description of lesions, location, and treatment response.
Patients presenting with itchy rashes or nail dystrophy.
Consideration of underlying conditions that may predispose to candidiasis.
Comprehensive history of immunocompromised status and previous infections.
Patients with recurrent infections or those on immunosuppressive therapy.
Need for thorough evaluation of potential systemic involvement.
Used when treating severe nail candidiasis.
Document the extent of debridement and reason for procedure.
Dermatology may require additional notes on nail health.
Common symptoms include redness, itching, scaling, and in the case of nails, discoloration and separation from the nail bed.
